Education *CME

June 10, 2021

It’s Time for a Change: IPC Psoriasis Severity Reclassification (CME)

Episode 131

Psoriasis classification is more than a BSA or PASI score. Listen as Dr. Bruce Strober, Clinical Professor of Dermatology at Yale University, New Haven, CT, and Dr. Andrew Blauvelt, President, Oregon Medical Research Center in Portland, OR, discuss the International Psoriasis Council's rationale for changing psoriasis severity classification for treatment decisions and clinical trials.

For disclosures and credits, visit this page.

This program is supported by educational grants from Lilly, Bristol Myers Squibb and Novartis.

Share
Related Items

Stay in the Know.

Expert tips, can’t-miss events and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity NavigatorMy Psoriasis Team logo

Copyright © 1996-2021 National Psoriasis Foundation/USA


Duplication, rebroadcast, republication or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).


NPF does not endorse or accept any responsibility for the content of external websites.


NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.